Cardiovascular Risk in Black South Africans (CRIBSA) Study
South Africa
Elvis Ndonwi, Keren de Buys, Don Matshazi, Naomi Levitt, Carl Lombard, Glenda Davison, Tandi Matsha, Andre Pascal Kengne, Sian Hemmings, Nasheeta Peer
Created on
January 28, 2025
Last modified
January 28, 2025
Page views
2491
Documentation in PDF
Metadata
DDI/XML
JSON
Identification
Survey ID Number
CRIBSAStudy
Title
Cardiovascular Risk in Black South Africans (CRIBSA) Study
Country
| Name | Country code |
|---|---|
| South Africa | RSA |
Abstract
Background: Our study investigated the association between transcription factor 7-like 2 (TCF7L2-rs7903146), angiotensin convertase enzyme (ACE-rs4646994), angiotensinogen (AGT-rs699), angiotensin II type 1 receptor (AGT1R-rs5186), fat mass and obesity-associated (FTO-rs17817499) and melanocortin 4 receptor (MC4R-rs17782313, rs12970134 and rs229616) single nucleotide polymorphisms (SNPs) with type 2 diabetes (T2D), obesity and hypertension in a Black South African population.
Methods: This cross-sectional study involved 560 Black South Africans aged 25 to 74 years. Participant demographic and lifestyle characteristics were self-reported; anthropometry and blood pressures (BP) measured; oral glucose tolerance tests used to diagnose T2D; and SNPs genotyped by polymerase chain reaction. The Benjamini-Hochberg method was used to control for multiple hypothesis testing, using a significance threshold of 0.12.
Results: Systolic BP was significantly higher in carriers of the G/G genotype of rs229616 within the MC4R gene compared to carriers of the G/A genotype (p = 0.006). In the same gene, logistic regression analysis showed that carriers of the minor C/C genotype of the rs17782313 SNP had a significantly higher risk of hypertension (OR = 1.37, p = 0.023). Moreover, carriers of the minor T/T genotype of the TCF7L2 rs7903146 SNP had a lower risk of T2D (OR = 0.66, p = 0.043).
Conclusion: TCF7L2-rs7903146 (C/C genotype) and MC4R-17782313 (C/C genotype) SNPs are potential genetic risk factors for T2D and hypertension in the Black South African population. Replicating these findings and exploring the role played by these genetic variants in downstream molecular pathways could aid in risk stratification and facilitate personalized approaches to healthcare delivery.
Methods: This cross-sectional study involved 560 Black South Africans aged 25 to 74 years. Participant demographic and lifestyle characteristics were self-reported; anthropometry and blood pressures (BP) measured; oral glucose tolerance tests used to diagnose T2D; and SNPs genotyped by polymerase chain reaction. The Benjamini-Hochberg method was used to control for multiple hypothesis testing, using a significance threshold of 0.12.
Results: Systolic BP was significantly higher in carriers of the G/G genotype of rs229616 within the MC4R gene compared to carriers of the G/A genotype (p = 0.006). In the same gene, logistic regression analysis showed that carriers of the minor C/C genotype of the rs17782313 SNP had a significantly higher risk of hypertension (OR = 1.37, p = 0.023). Moreover, carriers of the minor T/T genotype of the TCF7L2 rs7903146 SNP had a lower risk of T2D (OR = 0.66, p = 0.043).
Conclusion: TCF7L2-rs7903146 (C/C genotype) and MC4R-17782313 (C/C genotype) SNPs are potential genetic risk factors for T2D and hypertension in the Black South African population. Replicating these findings and exploring the role played by these genetic variants in downstream molecular pathways could aid in risk stratification and facilitate personalized approaches to healthcare delivery.
Producers and sponsors
Primary investigators
| Name | Affiliation |
|---|---|
| Elvis Ndonwi | SAMRC/CPUT, Cardiometabolic Health Research Unit, Department of Biomedical Sciences, Cape Peninsula University of Technology |
| Keren de Buys | SAMRC/Stellenbosch University Genomics of Brain Disorders Research Unit, Stellenbosch University |
| Don Matshazi | SAMRC/CPUT, Cardiometabolic Health Research Unit, Department of Biomedical Sciences, Cape Peninsula University of Technology |
| Naomi Levitt | Chronic Disease Initiative for Africa, Department of Medicine, University of Cape Town |
| Carl Lombard | Biostatistics Research Unit, South African Medical Research Council |
| Glenda Davison | SAMRC/CPUT, Cardiometabolic Health Research Unit, Department of Biomedical Sciences, Cape Peninsula University of Technology |
| Tandi Matsha | SAMRC/CPUT, Cardiometabolic Health Research Unit, Department of Biomedical Sciences, Cape Peninsula University of Technology |
| Andre Pascal Kengne | NCDRU, South African Medical Research Council |
| Sian Hemmings | Stellenbosch University Genomics of Brain Disorders Research Unit, Stellenbosch University |
| Nasheeta Peer | NCDRU, South African Medical Research Council |